Regenlab Usa Inc Files For IPO - SEC Filing
Regenlab Usa Inc Files For IPO - SEC Filing
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
RegenLab Files for IPO
By Katherine HamiltonRegenLab filed for an initial public offering.The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA.RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clin…
RegenLab, Regenerative Medicine Devices and PRP/HA Platforms, Files for Nasdaq IPO
RegenLab filed an S—1 on September 25, 2026 for an underwritten initial public offering. The company plans to list on the Nasdaq under the ticker “RGNA,” with StoneX Financial Inc. as sole book—running manager. The filing does not yet specify a price range or share count; proceeds are earmarked for…
RegenLab USA Files for IPO
RegenLab USA Files for IPO